WCM Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-102,234
Closed -$20.6M – 269
2025
Q4
$20.6M Buy
+102,234
New +$18.5M 0.04% 91
2024
Q4
– Sell
-10,367
Closed -$2.06M – 297
2024
Q3
$2.06M Buy
10,367
+2,589
+33% +$538K ﹤0.01% 201
2024
Q2
$1.61M Buy
7,778
+1,844
+31% +$418K ﹤0.01% 198
2024
Q1
$1.61M Buy
5,934
+87
+1% +$20.8K ﹤0.01% 191
2023
Q4
$1.4M Buy
+5,847
New +$1.15M ﹤0.01% 192
2021
Q2
– Sell
-23,440
Closed -$6.79M – 202
2021
Q1
$6.79M Sell
23,440
-25,514
-52% -$7.09M 0.02% 130
2020
Q4
$12.2M Buy
48,954
+207
+0.4% +$49.3K 0.03% 89
2020
Q3
$11M Sell
48,747
-3,652
-7% -$758K 0.04% 77
2020
Q2
$9.13M Buy
52,399
+2,044
+4% +$326K 0.04% 72
2020
Q1
$6.36M Buy
50,355
+14,103
+39% +$2.12M 0.04% 80
2019
Q4
$5.54M Buy
36,252
+26,379
+267% +$3.65M 0.03% 92
2019
Q3
$1.31M Buy
9,873
+46
+0.5% +$6.17K 0.01% 110
2019
Q2
$1.4M Sell
9,827
-215
-2% -$29.2K 0.01% 106
2019
Q1
$1.46M Buy
+10,042
New +$1.32M 0.01% 97

Other funds holding CRL

WCM Investment Management's CRL Position: Q1 2026 in Review

WCM Investment Management sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 102,234 shares — an estimated $20.6M sold.

WCM Investment Management first reported a position in CRL in Q1 2019 and held it in 14 quarters. The position peaked at $20.6M in Q4 2025. 560 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • WCM Investment Management reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • WCM Investment Management sold 102,234 Charles River Laboratories shares in Q1 2026, an estimated $20.6M.
  • WCM Investment Management first reported a position in Charles River Laboratories in Q1 2019 and held it in 14 quarters.
  • WCM Investment Management's Charles River Laboratories position peaked at $20.6M in Q4 2025.
  • 560 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on WCM Investment Management's 13F filing for Q1 2026, filed 7 May 2026.